Back
United Therapeutics Stock Price Chart
Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Buy
51
UTHR
United Therapeutics
Last Price:
$290.65
Seasonality Move:
9.4%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
United Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 290.36 | Buy |
| 20-day SMA: | 306.89 | Sell |
| 50-day SMA: | 300.2 | Sell |
| 200-day SMA: | 339.96 | Sell |
| 8-day EMA: | 292.97 | Sell |
| 20-day EMA: | 300.64 | Sell |
| 50-day EMA: | 305.6 | Sell |
| 200-day EMA: | 319.15 | Sell |
United Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.24 | Sell |
| Relative Strength Index (14 RSI): | 43.35 | Sell |
| Chaikin Money Flow: | 508777 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (290.98 - 321.96) | Sell |
| Bollinger Bands (100): | (289.58 - 344.14) | Sell |
United Therapeutics Technical Analysis
| Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 291.72 while UTHR 8-day simple moving average is 290.36, which is a Buy signal.
-
The stock price of UTHR is 291.72 while United Therapeutics 20-day SMA is 306.89, which makes it a Sell.
-
United Therapeutics 50-day simple moving average is 300.20 while UTHR share price is 291.72, making it a Sell technically.
-
UTHR stock price is 291.72 and United Therapeutics 200-day simple moving average is 339.96, creating a Sell signal.
UTHR Technical Analysis vs Fundamental Analysis
Buy
51
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a BuyThe current United Therapeutics [UTHR] share price is $291.72. The Score for UTHR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
United Therapeutics Stock Info
Market Cap:
13.2B
Price in USD:
291.72
Share Volume:
641.3K
United Therapeutics 52-Week Range
52-Week High:
417.82
52-Week Low:
266.98
Buy
51
United Therapeutics (UTHR)
is a Buy
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?The United Therapeutics stock price is 291.72 USD today.
-
Will UTHR stock go up or go down?United Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is not overvalued.
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 291.72 while UTHR 8-day exponential moving average is 292.97, which is a Sell signal.
-
The stock price of UTHR is 291.72 while United Therapeutics 20-day EMA is 300.64, which makes it a Sell.
-
United Therapeutics 50-day exponential moving average is 305.60 while UTHR share price is 291.72, making it a Sell technically.
-
UTHR stock price is 291.72 and United Therapeutics 200-day simple moving average is 319.15, creating a Sell signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.24 per share, an increase this year of $2.46 per share, and an increase next year of $1.06 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is -5.24, suggesting United Therapeutics is a Sell
-
United Therapeutics Relative Strength Index (RSI) is 43.35, which suggest United Therapeutics is oversold
-
The Bollinger Bands (25) for United Therapeutics is (290.98 - 321.96), which suggest United Therapeutics is a Sell
-
The Bollinger Bands (100) for United Therapeutics is (289.58 - 344.14), which suggest United Therapeutics is a Sell
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.